UK Posts Sovereign Regulatory System Proposals On Three Priority Areas
Patient safety and continuing access to products have steered UK Life Sciences Council advisory group proposals on recognition of overseas device approvals in Great Britain, speeding innovation to market and ensuring medtech regulatory system capacity.
You may also be interested in...
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills development and access to diagnosis and treatment.
Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.
The UK continues to work on its new medtech regulatory system and market access processes for innovations, but all the planning and preparations will count for little if not accompanied by sound execution, warns Lincoln Tsang of law firm Ropes & Gray.